Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi's R&D chief 'pretty pragmatic' about clinical setbacks
Houman Ashrafian, Ph.D., spoke to Fierce days before the company claimed a win for its anti-TNFa/OX40L nanobody in hidradenitis suppurativa.
James Waldron
Sep 17, 2025 8:01am
Sanofi becomes latest pharma to hold fire on UK R&D investments
Sep 15, 2025 10:14am
Sanofi phase 3 eczema win falls below analyst expectations
Sep 4, 2025 4:46am
Sanofi snags CMO from BioMarin—Chutes & Ladders
Aug 29, 2025 8:30am
Sanofi snags BioMarin leader to serve as CMO
Aug 26, 2025 11:06am
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm
